title: Comments on 'competing designs for drug combination in phase I dose-finding clinical trials' by M-K. Riviere, F. Dubois, S. Zohar.
authors.affiliation: Translational Research and Applied Statistics, Public Health Sciences, University of Virginia, Charlottesville, VA 22908, U.S.A.
authors.forename: Nolan A
authors.initials: NA
authors.lastname: Wages
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006801:Humans; D020714:Maximum Tolerated Dose
chemical_list: D000970:Antineoplastic Agents; D004338:Drug Combinations